The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of copanlisib in patients with tumors with PIK3CA mutations (PTEN loss allowed): NCI MATCH EAY131-Z1F.
Senthil Damodaran
Honoraria - Novartis
Consulting or Advisory Role - Pfizer; Taiho Pharmaceutical; Tempus
Research Funding - EMD Serono (Inst); Guardant Health (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Phillips Gilmore Oncology Communications
Fengmin Zhao
No Relationships to Disclose
Dustin A. Deming
Consulting or Advisory Role - Acrotech Biopharma; Array BioPharma; Bayer; Bristol-Myers Squibb; Genentech/Roche; Novocure; Promega; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Revolution Medicines (Inst)
Edith P. Mitchell
Honoraria - Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Merck; Novartis
Speakers' Bureau - Ipsen
Research Funding - Genentech (Inst); sanofi (Inst)
John Joseph Wright
No Relationships to Disclose
Laurence A Doyle
No Relationships to Disclose
Robert James Gray
Research Funding - Abbvie; Agios; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Genomic Health; Genzyme; GlaxoSmithKline; Janssen-Ortho; Merck Sharp & Dohme; Novartis; Onyx; Pfizer; Sanofi; Sequenta; Syndax; Takeda
Shuli Li
No Relationships to Disclose
Lisa McShane
No Relationships to Disclose
Larry V Rubinstein
No Relationships to Disclose
David R Patton
No Relationships to Disclose
Mickey Williams
No Relationships to Disclose
Stanley R. Hamilton
Stock and Other Ownership Interests - Johns Hopkins University School of Medicine
Consulting or Advisory Role - Bristol-Myers Squibb; Cell Medica/Kuur Therapeutics; Guardant Health; HalioDx; Loxo; Merck; Thermo Fisher Scientific
Jennifer Marie Suga
No Relationships to Disclose
Barbara A. Conley
No Relationships to Disclose
Carlos L. Arteaga
Leadership - American Association for Cancer Research
Stock and Other Ownership Interests - Provista Diagnostics; Y-Trap Inc.
Consulting or Advisory Role - Athenex; Clovis Oncology; Daiichi Sankyo; G1 Therapeutics; H3 Biomedicine; Immunomedics; Lilly; Merck; Novartis; Origimed; Petra Pharma; Puma Biotechnology; Radius Health; Sanofi; Symphogen; Taiho Pharmaceutical; Third Rock Ventures
Research Funding - Bayer; Lilly; Pfizer; Puma Biotechnology; Radius Health; Takeda
Other Relationship - Susan G. Komen for the Cure
Lyndsay Harris
Patents, Royalties, Other Intellectual Property - Philips Healthcare
Peter J. O'Dwyer
Consulting or Advisory Role - Array BioPharma; Genentech
Research Funding - Amgen; Array BioPharma (Inst); Bayer; BBI Healthcare; Bristol-Myers Squibb; Celgene; Five Prime Therapeutics; Forty Seven; Genentech; GlaxoSmithKline; H3 Biomedicine (Inst); Lilly/ImClone (Inst); Merck; Mirati Therapeutics; Novartis; Pfizer; Pharmacyclics; Taiho Pharmaceutical (Inst)
Expert Testimony - Bayer; Lilly
Alice P. Chen
No Relationships to Disclose
Keith Flaherty
Stock and Other Ownership Interests - Apricity Health; Checkmate Pharmaceuticals; Clovis Oncology; FOGPharma; Fount Therapeutics; Kinnate Biopharma; Loxo; Oncoceutics; PIC Therapeutics; Shattuck Labs; Strata Oncology; Tvardi Therapeutics; X4 Pharma
Consulting or Advisory Role - Adaptimmune; Aeglea Biotherapeutics; Amgen; Array BioPharma; Asana Biosciences; Boston Biomedical; Bristol-Myers Squibb; Cell Medica; Debiopharm Group; FOGPharma; Genentech; Incyte; Lilly; Loxo; Merck; Neon Therapeutics; Novartis; Oncoceutics; Pierre Fabre; Roche; Sanofi; Shattuck Labs; Takeda; Tolero Pharmaceuticals; Tvardi Therapeutics; Verastem
Research Funding - Novartis; Sanofi
Travel, Accommodations, Expenses - Debiopharm Group; Pierre Fabre